MAPROTILINE HYDROCHLORIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for maprotiline hydrochloride and what is the scope of patent protection?

Maprotiline hydrochloride is the generic ingredient in two branded drugs marketed by Novartis, Am Therap, Heritage Pharma, Rising, and Watson Labs, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for maprotiline hydrochloride.

Summary for MAPROTILINE HYDROCHLORIDE

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	11
Drug Master File Entries:	3
Raw Ingredient (Bulk) Api Vendors:	110
Clinical Trials:	3
Patent Applications:	1,258
What excipients (inactive ingredients) are in MAPROTILINE HYDROCHLORIDE?	MAPROTILINE HYDROCHLORIDE excipients list
DailyMed Link:	MAPROTILINE HYDROCHLORIDE at DailyMed

Recent Clinical Trials for MAPROTILINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Rochester	Phase 1
Hannover Medical School	Phase 3
US Department of Veterans Affairs	Phase 2

See all MAPROTILINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for MAPROTILINE HYDROCHLORIDE

Adrenergic Uptake Inhibitors
Antidepressive Agents, Second-Generation

Anatomical Therapeutic Chemical (ATC) Classes for MAPROTILINE HYDROCHLORIDE

N06AA	Non-selective monoamine reuptake inhibitors
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for MAPROTILINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	MAPROTILINE HYDROCHLORIDE	maprotiline hydrochloride	TABLET;ORAL	072285-003	Oct 3, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Am Therap	MAPROTILINE HYDROCHLORIDE	maprotiline hydrochloride	TABLET;ORAL	072129-001	Jan 14, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	MAPROTILINE HYDROCHLORIDE	maprotiline hydrochloride	TABLET;ORAL	071944-001	Dec 30, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.